TCMG
CLDX icon

TSP Capital Management Group’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-335,977
Closed -$6.1M 19
2025
Q1
$6.1M Buy
335,977
+112,634
+50% +$2.04M 2.01% 21
2024
Q4
$5.64M Sell
223,343
-24,477
-10% -$619K 1.92% 21
2024
Q3
$8.42M Sell
247,820
-1,400
-0.6% -$47.6K 2.61% 17
2024
Q2
$9.22M Hold
249,220
2.89% 18
2024
Q1
$10.5M Sell
249,220
-2,275
-0.9% -$95.5K 3.37% 14
2023
Q4
$9.97M Sell
251,495
-200
-0.1% -$7.93K 3.46% 13
2023
Q3
$6.93M Sell
251,695
-200
-0.1% -$5.5K 2.67% 19
2023
Q2
$8.55M Sell
251,895
-500
-0.2% -$17K 3.08% 17
2023
Q1
$9.08M Sell
252,395
-17,500
-6% -$630K 3.28% 15
2022
Q4
$12M Buy
+269,895
New +$12M 4.5% 5
2022
Q3
Hold
0
16
2022
Q2
Hold
0
18
2022
Q1
Hold
0
17
2021
Q4
Hold
0
14
2021
Q3
Hold
0
4
2021
Q2
Sell
-359,229
Closed -$7.4M 10
2021
Q1
$7.4M Sell
359,229
-44,000
-11% -$906K 2.61% 17
2020
Q4
$7.07M Buy
+403,229
New +$7.07M 2.51% 18
2020
Q3
Hold
0
19
2020
Q2
Hold
0
21
2020
Q1
Hold
0
39
2019
Q4
Hold
0
42
2019
Q3
Hold
0
50
2019
Q2
Hold
0
52
2019
Q1
Sell
-236,919
Closed -$1.2M 43
2018
Q4
$1.2M Buy
+236,919
New +$1.2M 0.67% 38
2018
Q3
Sell
-1,328,207
Closed -$669K 35
2018
Q2
$669K Sell
1,328,207
-108,750
-8% -$54.8K 0.34% 46
2018
Q1
$3.35M Buy
1,436,957
+158,900
+12% +$370K 1.6% 26
2017
Q4
$3.63M Buy
1,278,057
+119,338
+10% +$339K 1.65% 22
2017
Q3
$3.31M Buy
+1,158,719
New +$3.31M 1.58% 24
2017
Q2
Hold
0
25
2017
Q1
Hold
0
23
2016
Q4
Hold
0
21
2016
Q3
Sell
-818,473
Closed -$3.59M 21
2016
Q2
$3.59M Sell
818,473
-37,450
-4% -$164K 1.86% 20
2016
Q1
$3.24M Buy
855,923
+24,275
+3% +$91.7K 1.78% 21
2015
Q4
$13M Buy
831,648
+6,967
+0.8% +$109K 6.97% 1
2015
Q3
$8.69M Buy
824,681
+12,000
+1% +$126K 4.88% 2
2015
Q2
$20.5M Buy
+812,681
New +$20.5M 9.53% 1
2015
Q1
Hold
0
1
2014
Q4
Hold
0
1
2014
Q3
Sell
-811,267
Closed -$13.2M 2
2014
Q2
$13.2M Buy
+811,267
New +$13.2M 5.75% 1
2014
Q1
Hold
0
1
2013
Q4
Hold
0
1
2013
Q3
Hold
0
1
2013
Q2
Hold
0
1